A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays
- 30 April 2009
- journal article
- research article
- Published by Elsevier BV in Antiviral Research
- Vol. 82 (1), 12-21
- https://doi.org/10.1016/j.antiviral.2009.01.001
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inhibition of human parainfluenza virus type 3 infection by novel small moleculesAntiviral Research, 2008
- A cell-based luminescence assay is effective for high-throughput screening of potential influenza antiviralsAntiviral Research, 2007
- Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2006
- Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway EpitheliumJournal of Virology, 2005
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Genetic Characterization of Parainfluenza Virus 3 Derived from Guinea Pigs.The Journal of Veterinary Medical Science, 1998
- The complete nucleotide sequence of the JS strain of human parainfluenza virus type 3: comparison with the Wash/47885/57 prototype strainVirus Research, 1992
- A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNANature, 1991
- Dye Uptake Methods for Assessing Viral Cytopathogenicity and their Application to Interferon AssaysJournal of General Virology, 1969